The wait of the people of the country for the Corona vaccine is over. Indigenous Kovaxin of Bharat Biotech and the Emergency Use of Kovshield of Serum Institute have been approved by the Drugs Controller General of India (DCGI). On the other hand, Zaykov-D of Zydus Cadila Healthcare has been approved for Phase-3 trial. DCGI gave this information at a press conference on Sunday.
The Subject Expert Committee on Corona on Saturday prescribed restrictive endorsement of Bharat Biotech to Covaxin for crisis use. Prior on Friday, the CoviShield of the Serum Institute was prescribed to give a comparative endorsement. With the endorsement of both, it is currently expected that the immunization drive will begin from this week itself. Immunization dry run has additionally begun in the whole nation to test the arrangements.
PM Modi Tweet –
It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion.
